Cleared Traditional

K214063 - Model 121 Biopsy Needle, Model 111 Biopsy Needle, Model 112 Biopsy Needle, and Model 131 Disposable Coaxial Biopsy Needle (FDA 510(k) Clearance)

Jun 2022
Decision
158d
Days
Class 2
Risk

K214063 is an FDA 510(k) clearance for the Model 121 Biopsy Needle, Model 111 Biopsy Needle, Model 112 Biopsy Needle, and Model 131 Disposable Coaxial Biopsy Needle. This device is classified as a Instrument, Biopsy (Class II - Special Controls, product code KNW).

Submitted by Guangzhou Shengwei Medical Devices Co., Ltd. (Conghua City, CN). The FDA issued a Cleared decision on June 3, 2022, 158 days after receiving the submission on December 27, 2021.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1075.

Submission Details

510(k) Number K214063 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2021
Decision Date June 03, 2022
Days to Decision 158 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code KNW - Instrument, Biopsy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1075

Similar Devices - KNW Instrument, Biopsy

All 11
Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module
K260365 · Devicor Medical Products, Inc. · Mar 2026
ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit)
K252795 · Argon Medical Devices, Inc. · Feb 2026
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
K252681 · Bard Peripheral Vascular, Inc. · Dec 2025
Marquee™ Disposable Core Biopsy Instrument and Instrument Kit
K250032 · Bard Peripheral Vascular, Inc. · Jul 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K243945 · SurGenTec, LLC · Apr 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K240664 · SurGenTec, LLC · Aug 2024